SCHEMBL30104708

SCHEMBL30104708

C/C(I)=C/C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AR P10275 6/20 0.49
TAS2R14 Q9NYV8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26364955 0.90 AR (0.51) ARTAS2R14
SCHEMBL14289402 0.83 AR (0.59) AR
SCHEMBL26364970 0.82 AR (0.55) AR
SCHEMBL30104645 0.82 AR (0.55) AR
SCHEMBL28904279 0.82 AR (0.51) ARTAS2R14
SCHEMBL21924973 0.82 TGM2 (0.54) ARTAS2R14
SCHEMBL2132359 0.81 AR (0.53) AR
SCHEMBL5664793 0.80 AR (0.55) ARTAS2R14
SCHEMBL17658051 0.80 BLM (0.63) ARTAS2R14
SCHEMBL10811597 0.80 AR (0.51) ARTAS2R14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110322-A1 SELECTIVE ANDROGEN RECEPTOR COVALENT ANTAGONISTS (SARCAS) AND METHODS OF USE THEREOF University of Tennessee Research Foundation (US) 2023-01-04 EP disclosed